ArticleCell reports. Medicine2025

System analysis links SMARCD3 regulons to growth signaling and MEK inhibitor response in everolimus-resistant ER+ breast cancer cells.

Eric F Medina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.